HuGE Literature Finder
|
||
Records 1-11
|
Bulky DNA adduct levels in normal-appearing colon mucosa, and the prevalence of colorectal adenomas.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2018 Jun 1-23. Ho Vikki, Peacock Sarah, Massey Thomas E, Godschalk Roger W L, van Schooten Frederik J, Ashbury Janet E, Vanner Stephen J, King Will |
|
Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies?
The pharmacogenomics journal 2013 Oct 13 (5): 423-9. Loh M, Chua D, Yao Y, Soo R A, Garrett K, Zeps N, Platell C, Minamoto T, Kawakami K, Iacopetta B, Soong |
|
The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer.
Molecular biology reports 2012 Jan 39 (1): 527-34. Gil Justyna, Ramsey Dave, Stembalska Agnieszka, Karpinski Pawel, Pesz Karolina A, Laczmanska Izabela, Leszczynski Przemyslaw, Grzebieniak Zygmunt, Sasiadek Maria Malgorza |
|
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.
The pharmacogenomics journal 2011 Dec 11 (6): 437-43. Ho-Pun-Cheung A, Assenat E, Bascoul-Mollevi C, Bibeau F, Boissière-Michot F, Thezenas S, Cellier D, Azria D, Rouanet P, Senesse P, Ychou M, Lopez-Crapez |
|
DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas.
Carcinogenesis 2011 Jun 32 (6): 882-7. Gao Ying, Hayes Richard B, Huang Wen-Yi, Caporaso Neil E, Burdette Laurie, Yeager Meredith, Chanock Stephen J, Berndt Sonja |
|
Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population.
Journal of applied genetics 2010 51 (3): 343-52. Jelonek K, Gdowicz-Klosok A, Pietrowska M, Borkowska M, Korfanty J, Rzeszowska-Wolny J, Widlak |
|
Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array.
British journal of cancer 2009 Jul 101 (2): 357-62. Kweekel D M, Antonini N F, Nortier J W R, Punt C J A, Gelderblom H, Guchelaar H |
|
Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk.
Carcinogenesis 2009 Mar 30 (3): 472-9. Joshi Amit D, Corral Román, Siegmund Kimberly D, Haile Robert W, Le Marchand Loïc, Martínez Maria Elena, Ahnen Dennis J, Sandler Robert S, Lance Peter, Stern Mariana |
|
XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.
Mutation research 2007 Jun 619 (1-2): 68-80. Hansen Rikke Dalgaard, Sørensen Mette, Tjønneland Anne, Overvad Kim, Wallin Håkan, Raaschou-Nielsen Ole, Vogel Ul |
|
Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.
Oncology 2007 72 (5-6): 364-70. Monzo Mariano, Moreno Isabel, Navarro Alfons, Ibeas Rafael, Artells Rosa, Gel Bernat, Martinez Francisco, Moreno Jose, Hernandez Raquel, Navarro-Vigo Mar |
|
A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.
British journal of cancer 2004 Jul 91 (2): 344-54. Stoehlmacher J, Park D J, Zhang W, Yang D, Groshen S, Zahedy S, Lenz H |
- Page last reviewed:Jul 30, 2019
- Page last updated:Nov 21, 2019
- Content source: